MIND Foods and Aerobic Training in Black Adults With HTN
Conditions: Cognitive Decline; Hypertension; Diet; Aerobic Exercise Interventions: Behavioral: Enhanced Usual Care (EUC); Behavioral: Food Delivery and Cooking PLUS Aerobic Training (FoRKS+) Sponsors: Indiana University; National Institutes of Health (NIH); National Institute on Aging (NIA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
UCSF BP Activate Letter Study
Conditions: Hypertension Interventions: Other: BP Activate Letter; Other: Control Letter Sponsors: University of California, San Francisco Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Lorundrostat Alone, and in Combination With Dapagliflozin in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria
Conditions: Chronic Kidney Disease Interventions: Drug: Part A - Lorundrostat QD + Dapaglifozin QD; Drug: Part A - Lorundrostat QD; Drug: Part B - Lorundrostat QD Open Label Sponsors: Mineralys Therapeutics Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials
A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)
Conditions: Coarctation of Aorta; High Blood Pressure Interventions: Drug: Losartan; Drug: Amlodipine; Drug: Placebo Sponsors: Mayo Clinic; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials
Randomized Controlled Trial of the Smart O2O Model Development for Chronic Diseases Management Through Digital Health
Conditions: Hypertension; Diabete Mellitus Interventions: Behavioral: O2O digital healthcare service Sponsors: Seoul National University Hospital; Korea Health Industry Development Institute; Seoul National University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials
Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of CSPH in Patients With cACLD
Conditions: Liver Cirrhosis; Liver Fibrosis; Portal Hypertension Interventions: Diagnostic Test: Diagnostic Test: Transient elastography (TE) and 2D-shear wave elastography (2D-SWE) Sponsors: Fifth Affiliated Hospital, Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
A Study of LY3971297 in Healthy Participants and Participants With Obesity and Hypertension
Conditions: Healthy; Obesity; Hypertension Interventions: Drug: LY3971297; Drug: Placebo Sponsors: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
Effectiveness of a Community Pharmacy-based Health Promotion Program on Hypertension in Bangladesh and Pakistan
Conditions: Blood Pressure; Pharmacy; Cost-effectiveness Interventions: Behavioral: Pharmacy based health promotion Sponsors: Hitotsubashi University; Global Public Health Research Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1}
This study is being performed as a randomized, multicenter, open-label, parallel-group, clinical trial in which 720 participants are to undergo 24-h ambulatory blood pressure measurement (ABPM) and office blood pressure measurement (OBPM) at baseline before being randomly assigned to a morning (6 –10 am) or a bedtime (6–10 pm) administration group. Each participant receives one 20/5-mg tablet of olmesartan/amlodipine (OA) daily for 4 weeks and is then followed up at 4-week intervals for a total of 12 weeks. During follow-up, the OA dosage is adjusted according to the ABPM and OBPM result s. Patients with uncontrolled h...
Source: Trials - November 28, 2023 Category: Research Source Type: clinical trials
Maternal & Infant Morbidity and Mortality
Conditions: Preg Complications: Hemorrhagic; Infant, Premature, Diseases; Preg Complications: Hemorrhagic Intervillous of Placenta; Preg Complications: Bleeding From Female Genital Tract; Preg Complic - Malig Hypertension and / or Reason for Care During Childbirth Interventions: Other: Pregnant Women Sponsors: University of Virginia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
ADOPT: Improving Diagnosis of Pulmonary Hypertension With AI and Echo
Conditions: Pulmonary Hypertension Interventions: Diagnostic Test: Artificial intelligence tool for transthoracic echocardiography Sponsors: Royal United Hospitals Bath NHS Foundation Trust; Janssen Research& Development, LLC; Royal Free Hospital NHS Foundation Trust; Sheffield Teaching Hospitals NHS Foundation Trust; Royal Papworth Hospital NHS Foundation Trust; NHS Golden Jubilee National Hospital Glasgow Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
Phase 2, Placebo-Controlled, Study Assessing the Safety and Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Patients With Elevated Eye Pressure
Conditions: Primary Open Angle Glaucoma; Ocular Hypertension Interventions: Drug: SBI-100 Ophthalmic Emulsion, 0.5%; Drug: SBI-100 Ophthalmic Emulsion, 1.0%; Drug: SBI-100 Ophthalmic Emulsion, Placebo Sponsors: Skye Bioscience, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Prediction of Portal Hypertension in Patients With CVID (CVID-pHT)
Conditions: Non-Cirrhotic Portal Hypertension; Common Variable Immunodeficiency Interventions: Diagnostic Test: Ultrasound including color doppler ultrasound Sponsors: University Hospital Freiburg Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of GOV in Patients With cACLD
Conditions: Liver Cirrhosis; Liver Fibrosis; Portal Hypertension Interventions: Diagnostic Test: Transient elastography (TE) and 2D-shear wave elastography (2D-SWE) Sponsors: Fifth Affiliated Hospital, Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Polypill for Prevention of Cardiomyopathy
Conditions: Type 2 Diabetes; High Blood Pressure Interventions: Drug: Polypill Sponsors: University of Texas Southwestern Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
